Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates

SHIVERS

doi:10.2807/1560-7917.ES.2016.21.1.30101

Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates

SHIVERS

Institute of Tropical Medicine

Research output: Contribution to journal › A1: Web of Science-article › peer-review

6 Downloads (Pure)

Abstract

Preliminary results for influenza vaccine effectiveness (VE) against acute respiratory illness with circulating laboratory-confirmed influenza viruses in New Zealand from 27 April to 26 September 2015, using a case test-negative design were 36% (95% confidence interval (CI): 11-54) for general practice encounters and 50% (95% CI: 20-68) for hospitalisations. VE against hospitalised influenza A(H3N2) illnesses was moderate at 53% (95% CI: 6-76) but improved compared with previous seasons.

Original language	English
Article number	30101
Journal	Eurosurveillance
Volume	21
Issue number	1
Number of pages	5
ISSN	1560-7917
DOIs	https://doi.org/10.2807/1560-7917.ES.2016.21.1.30101
Publication status	Published - 2016

Keywords

Adolescent
Adult
Aged
Case-Control Studies
Child
Child, Preschool
Female
Hospitalization/statistics & numerical data
Humans
Infant
Infant, Newborn
Influenza A Virus, H1N1 Subtype/genetics
Influenza Vaccines/administration & dosage
Influenza, Human/epidemiology
Logistic Models
Male
Middle Aged
Multivariate Analysis
New Zealand/epidemiology
Primary Health Care
Reverse Transcriptase Polymerase Chain Reaction
Seasons
Sentinel Surveillance
Urban Population/statistics & numerical data
Vaccination
Young Adult

Access to Document

10.2807/1560-7917.ES.2016.21.1.30101Licence: Unspecified

2016euro30101Licence: Unspecified

Cite this

@article{6ea7831e0ea84ca5a128697849719611,

title = "Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates",

abstract = "Preliminary results for influenza vaccine effectiveness (VE) against acute respiratory illness with circulating laboratory-confirmed influenza viruses in New Zealand from 27 April to 26 September 2015, using a case test-negative design were 36% (95% confidence interval (CI): 11-54) for general practice encounters and 50% (95% CI: 20-68) for hospitalisations. VE against hospitalised influenza A(H3N2) illnesses was moderate at 53% (95% CI: 6-76) but improved compared with previous seasons. ",

keywords = "Adolescent, Adult, Aged, Case-Control Studies, Child, Child, Preschool, Female, Hospitalization/statistics & numerical data, Humans, Infant, Infant, Newborn, Influenza A Virus, H1N1 Subtype/genetics, Influenza Vaccines/administration & dosage, Influenza, Human/epidemiology, Logistic Models, Male, Middle Aged, Multivariate Analysis, New Zealand/epidemiology, Primary Health Care, Reverse Transcriptase Polymerase Chain Reaction, Seasons, Sentinel Surveillance, Urban Population/statistics & numerical data, Vaccination, Young Adult",

author = "SHIVERS and A Bissielo and N Pierse and Huang, {Q S} and Thompson, {M G} and H Kelly and Mishin, {V P} and N Turner and Marc-Alain Widdowson",

note = "FTX; DOAJ",

year = "2016",

doi = "10.2807/1560-7917.ES.2016.21.1.30101",

language = "English",

volume = "21",

journal = "Eurosurveillance",

issn = "1560-7917",

publisher = "European Centre for Disease Prevention & Control",

number = "1",

}

TY - JOUR

T1 - Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates

AU - SHIVERS

AU - Bissielo, A

AU - Pierse, N

AU - Huang, Q S

AU - Thompson, M G

AU - Kelly, H

AU - Mishin, V P

AU - Turner, N

AU - Widdowson, Marc-Alain

N1 - FTX; DOAJ

PY - 2016

Y1 - 2016

N2 - Preliminary results for influenza vaccine effectiveness (VE) against acute respiratory illness with circulating laboratory-confirmed influenza viruses in New Zealand from 27 April to 26 September 2015, using a case test-negative design were 36% (95% confidence interval (CI): 11-54) for general practice encounters and 50% (95% CI: 20-68) for hospitalisations. VE against hospitalised influenza A(H3N2) illnesses was moderate at 53% (95% CI: 6-76) but improved compared with previous seasons.

AB - Preliminary results for influenza vaccine effectiveness (VE) against acute respiratory illness with circulating laboratory-confirmed influenza viruses in New Zealand from 27 April to 26 September 2015, using a case test-negative design were 36% (95% confidence interval (CI): 11-54) for general practice encounters and 50% (95% CI: 20-68) for hospitalisations. VE against hospitalised influenza A(H3N2) illnesses was moderate at 53% (95% CI: 6-76) but improved compared with previous seasons.

KW - Adolescent

KW - Adult

KW - Aged

KW - Case-Control Studies

KW - Child

KW - Child, Preschool

KW - Female

KW - Hospitalization/statistics & numerical data

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Influenza A Virus, H1N1 Subtype/genetics

KW - Influenza Vaccines/administration & dosage

KW - Influenza, Human/epidemiology

KW - Logistic Models

KW - Male

KW - Middle Aged

KW - Multivariate Analysis

KW - New Zealand/epidemiology

KW - Primary Health Care

KW - Reverse Transcriptase Polymerase Chain Reaction

KW - Seasons

KW - Sentinel Surveillance

KW - Urban Population/statistics & numerical data

KW - Vaccination

KW - Young Adult

U2 - 10.2807/1560-7917.ES.2016.21.1.30101

DO - 10.2807/1560-7917.ES.2016.21.1.30101

M3 - A1: Web of Science-article

C2 - 26767540

SN - 1560-7917

VL - 21

JO - Eurosurveillance

JF - Eurosurveillance

IS - 1

M1 - 30101

ER -

Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates

Abstract

Keywords

Access to Document

Fingerprint

Cite this